Owkin
Jean-Yves Blay is a medical oncologist who currently serves as a scientific advisor at Owkin. Jean-Yves was previously employed at the European Organisation for Research and Treatment of Cancer, Netsarc, EORTC, Centre Leon Berard, French Sarcoma Group, Conticanet, Université Claude Bernard Lyon, and the Centre Leon. Blay has dedicated their career to cancer research and treatment and has amassed a wealth of experience in the field.
Jean-Yves Blay is a medical doctor who has also obtained a PhD and a Master's in statistics. Jean-Yves is board certified in medical oncology and FMGEMS, and their educational background is in medicine and biomedical research. Jean-Yves attended baccalaureat at the University of Paris VII & XI, and then went on to complete their Internship at Institut Gustave Roussy. After obtaining their Master's in statistics, they completed a Master's in biomedical science.
This person is not in the org chart
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.